Viatris (VTRS) - Stock Price & Dividends

Viatris Inc., listed on NASDAQ as VTRS, is a global healthcare company that operates worldwide. The company's operations are divided into four segments: Developed Markets, Greater China, JANZ, and Emerging Markets.

Viatris offers a wide range of pharmaceutical products, including prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). Their portfolio covers various therapeutic areas such as noncommunicable and infectious diseases, oncology, immunology, endocrinology, ophthalmology, and dermatology.

In addition to medications, Viatris provides support services to help patients manage their health better, including diagnostic clinics, educational seminars, and digital tools. Their products come in various forms like oral solid doses, injectables, complex dosage forms, and APIs, serving retail and pharmacy establishments, wholesalers, distributors, payers, insurers, governments, and institutions.

The company distributes its products through a variety of channels like pharmaceutical wholesalers/distributors, retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. Some of the well-known product names under which Viatris sells its medications are Lyrica, Lipitor, Creon, Celebrex, Norvasc, Viagra, Effexor, and EpiPen.

Viatris Inc. was established in 1961 and has its headquarters located in Canonsburg, Pennsylvania. For more information about Viatris, you can visit their website at https://www.viatris.com.